About Index Trending news
SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.


Contributors to this profile

Alexa global traffic share

Twitter followers

23 Apr 2017

SteadyMed raises $30m for Trevyent commercial launch

Drug Delivery Business
30 Jul 2016
Post-IPO equity
OrbiMed, Deerfield Capital Management, Federated Investors
03 Feb 2015
Venture capital
08 Apr 2013
Debt financing
17 Sep 2012
Venture capital
28 Jan 2009
Venture capital (Series A)